Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen)
Übersicht


Zum ersten Bild Abb. 7: Telmisartan - Losartan Abb. 8: Telmisartan - Losartan Abb. 9: Telmisartan - Losartan Aktuelles Bild - Abb. 10: Telmisartan - Losartan Abb. 11: Telmisartan - Losartan - Studienverlauf Abb. 12: Telmisartan - Losartan - Systolischer Minimaldruck Abb. 13: Telmisartan - Valsartan Zum letzten Bild
Abbildung 10: Telmisartan - Losartan
In a meta-analysis of two flexible-dose studies, telmisartan produced superior reductions in blood pressure than losartan. These data are from two 8-week studies in 720 patients with mild-to-moderate hypertension.1 Patients were started at the lower dose, with up-titration to the higher dose allowed if seated trough cuff DBP was ≥90 mmHg at Week 4. By Week 8, the reduction in SBP and DBP in the last 6 h of the dosing interval was greater in the telmisartan arm than in the losartan arm. Telmisartan-induced reductions were also greater for the majority of the observed hourly mean ambulatory SBP and DBP values over the entire 24-h dosing interval. 1. Smith DH, et al. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies. Blood Press Monit 2003;8:111–117.
 
Telmisartan - Losartan
Vorheriges Bild Nächstes Bild   


Abbildung 10: Telmisartan - Losartan
In a meta-analysis of two flexible-dose studies, telmisartan produced superior reductions in blood pressure than losartan. These data are from two 8-week studies in 720 patients with mild-to-moderate hypertension.1 Patients were started at the lower dose, with up-titration to the higher dose allowed if seated trough cuff DBP was ≥90 mmHg at Week 4. By Week 8, the reduction in SBP and DBP in the last 6 h of the dosing interval was greater in the telmisartan arm than in the losartan arm. Telmisartan-induced reductions were also greater for the majority of the observed hourly mean ambulatory SBP and DBP values over the entire 24-h dosing interval. 1. Smith DH, et al. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies. Blood Press Monit 2003;8:111–117.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung